journal article·2026-04-03

Bioorganic design of metal–organic frameworks for targeted and stimuli-responsive anticancer drug delivery

Rohit Sharma, Thakur Gurjeet Singh, Keshav Raj Paudel, Kamal Dua, Avneet Kour, Dinesh Kumar Chellappan, Poonam Negi

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263. https://doi.org/10.3322/caac.2183410.3322/caac.21834 ↗
2. Zafar A, Khatoon S, Khan MJ et al (2025) Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov Oncol 16(1):607. https://doi.org/10.1007/s12672-025-02198-810.1007/s12672-025-02198-8 ↗
3. Hopper C (2000) Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 1(4):212–219. https://doi.org/10.1016/s1470-2045(00)00166-210.1016/s1470-2045(00)00166-2 ↗
4. Mahvi DA, Liu R, Grinstaff MW et al (2018) Local cancer recurrence: the realities, challenges, and opportunities for new therapies. CA Cancer J Clin 68(6):488–505. https://doi.org/10.3322/caac.2149810.3322/caac.21498 ↗
5. Baldo BA, Pham NH (2013) Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch. Cancer Metastasis Rev 32(3):723–76110.1007/s10555-013-9447-3 ↗
6. Yin ZS, Wang Z (2024) Strategies for engineering oncolytic viruses to enhance cancer immunotherapy. Front Pharmacol 15:1450203. https://doi.org/10.3389/fphar.2024.145020310.3389/fphar.2024.1450203 ↗
7. Wang K, Tepper JE (2021) Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J Clin 71(5):437–454. https://doi.org/10.3322/caac.2168910.3322/caac.21689 ↗
8. Kim BM, Hong Y, Lee S et al (2015) Therapeutic implications for overcoming radiation resistance in cancer therapy. Int J Mol Sci 16(11):26880–26913. https://doi.org/10.3390/ijms16112599110.3390/ijms161125991 ↗
9. Rau KM, Kang HY, Cha TL et al (2005) The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers. Endocr Relat Cancer 12(3):511–532. https://doi.org/10.1677/erc.1.0102610.1677/erc.1.01026 ↗
10. Chaudhry P, Asselin E (2009) Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer 16(2):363–380. https://doi.org/10.1677/ERC-08-026610.1677/ERC-08-0266 ↗
11. Sharma R, Komal K, Kumar S et al (2025) A comprehensive review on revolutionizing pancreatic cancer treatment: liposomal innovations. J Drug Deliv Sci Technol 110:107032. https://doi.org/10.1016/j.jddst.2025.10703210.1016/j.jddst.2025.107032 ↗
12. Tan S, Li D, Zhu X (2020) Cancer immunotherapy: pros, cons and beyond. Biomed Pharmacother 124:109821. https://doi.org/10.1016/j.biopha.2020.10982110.1016/j.biopha.2020.109821 ↗
13. Liu J, Huang J, Zhang L et al (2021) Multifunctional metal-organic framework heterostructures for enhanced cancer therapy. Chem Soc Rev 50(2):1188–1218. https://doi.org/10.1039/d0cs00178c10.1039/d0cs00178c ↗
14. Salehi MM, Esmailzadeh F, Hassanzadeh-Afruzi F (2023) Applications of MOFs. In: Maleki A, Taheri-Ledari R (eds) Physicochemical aspects of metal–organic Frameworks: a new class of coordinative materials. Springer, Cham, pp 197–30510.1007/978-3-031-18675-2_13 ↗
15. Altaf A, Khan I, Khan A et al (2024) Metal/covalent organic framework encapsulated lead-free halide perovskite hybrid nanocatalysts: Multifunctional applications, design, recent trends, challenges, and prospects. ACS Omega 9(32):34220–3424210.1021/acsomega.4c04532 ↗
16. Guo Z, Xiao Y, Wu W et al (2025) Metal–organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances, challenges, and future perspectives. J Nanobiotechnology 23(1):157. https://doi.org/10.1186/s12951-025-03252-x10.1186/s12951-025-03252-x ↗
17. Shano LB, Karthikeyan S, Kennedy LJ et al (2024) MOFs for next-generation cancer therapeutics through a biophysical approach-a review. Front Bioeng Biotechnol 12:1397804. https://doi.org/10.3389/fbioe.2024.139780410.3389/fbioe.2024.1397804 ↗
18. Cai M, Chen G, Qin L et al (2020) Metal organic frameworks as drug TARGETING delivery vehicles in the treatment of cancer. Pharmaceutics. https://doi.org/10.3390/pharmaceutics1203023210.3390/pharmaceutics12030232 ↗
19. Ashique S, Sandhu NK, Chawla V et al (2021) Targeted drug delivery: trends and perspectives. Curr Drug Deliv 18(10):1435–1455. https://doi.org/10.2174/156720181866621060916130110.2174/1567201818666210609161301 ↗
20. Al Bostami RD, Abuwatfa WH, Husseini GA (2022) Recent advances in nanoparticle-based co-delivery systems for cancer therapy. Nanomaterials 12(15):267210.3390/nano12152672 ↗
21. Sharma R, Kumar S, Komal K et al (2025) Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine. Naunyn Schmiedebergs Arch Pharmacol. https://doi.org/10.1007/s00210-025-04094-y10.1007/s00210-025-04094-y ↗
22. Wen T, Quan G, Niu B et al (2021) Versatile nanoscale metal–organic frameworks (nMOFs): an emerging 3D nanoplatform for drug delivery and therapeutic applications. Small 17(8):e2005064. https://doi.org/10.1002/smll.20200506410.1002/smll.202005064 ↗
23. Chen X, Argandona SM, Melle F et al (2024) Advances in surface functionalization of next-generation metal–organic frameworks for biomedical applications: design, strategies, and prospects. Chem 10(2):504–54310.1016/j.chempr.2023.09.016 ↗
24. Li B, Ashrafizadeh M, Jiao T (2024) Biomedical application of metal–organic frameworks (MOFs) in cancer therapy: stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis. Int J Biol Macromol 260:12939110.1016/j.ijbiomac.2024.129391 ↗
25. Giordano A, Provenza AC, Reverchon G et al (2024) Lipid-based nanocarriers: bridging diagnosis and cancer therapy. Pharmaceutics 16(9):1158. https://doi.org/10.3390/pharmaceutics1609115810.3390/pharmaceutics16091158 ↗
26. Han Y, Liu W, Huang J et al (2018) Cyclodextrin-based metal–organic frameworks (CD-MOFs) in pharmaceutics and biomedicine. Pharmaceutics 10(4):271. https://doi.org/10.3390/pharmaceutics1004027110.3390/pharmaceutics10040271 ↗
27. Nasrollahi M, Nabipour H, Valizadeh N et al (2020) The role of flexibility in MOFs. In: Mozafari M (ed) Metal–organic frameworks for biomedical applications. Woodhead Publishing, Cambridge, pp 93–110. https://doi.org/10.1016/b978-0-12-816984-1.00006-810.1016/b978-0-12-816984-1.00006-8 ↗
28. Kalmutzki MJ, Hanikel N, Yaghi OM (2018) Secondary building units as the turning point in the development of the reticular chemistry of MOFs. Sci Adv 4(10):eaat9180. https://doi.org/10.1126/sciadv.aat918010.1126/sciadv.aat9180 ↗
29. Lawson HD, Walton SP, Chan C (2021) Metal-organic frameworks for drug delivery: a design perspective. ACS Appl Mater Interfaces 13(6):7004–7020. https://doi.org/10.1021/acsami.1c0108910.1021/acsami.1c01089 ↗
30. Furukawa H, Cordova KE, O’Keeffe M et al (2013) The chemistry and applications of metal–organic frameworks. Science 341(6149):1230444. https://doi.org/10.1126/science.123044410.1126/science.1230444 ↗
31. Rojas S, Devic T, Horcajada P (2017) Metal organic frameworks based on bioactive components. J Mater Chem B 5(14):2560–2573. https://doi.org/10.1039/c6tb03217f10.1039/c6tb03217f ↗
32. Osterrieth JWM, Fairen-Jimenez D (2021) Metal–organic framework composites for theragnostics and drug delivery applications. Biotechnol J 16(2):e2000005. https://doi.org/10.1002/biot.20200000510.1002/biot.202000005 ↗
33. Abánades Lázaro I, Chen X, Ding M et al (2024) Metal–organic frameworks for biological applications. Nat Rev Methods Prim 4(1):4210.1038/s43586-024-00320-8 ↗
34. Sezgin P, Gulcay-Ozcan E, Vuckovski M et al (2025) Biomedical applications of metal-organic frameworks revisited. Ind Eng Chem Res 64(4):1907–1932. https://doi.org/10.1021/acs.iecr.4c0369810.1021/acs.iecr.4c03698 ↗
35. Arner EN, Rathmell JC (2023) Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41(3):421–433. https://doi.org/10.1016/j.ccell.2023.01.00910.1016/j.ccell.2023.01.009 ↗
36. Horcajada P, Serre C, Vallet-Regi M et al (2006) Metal-organic frameworks as efficient materials for drug delivery. Angew Chem Int Ed Engl 45(36):5974–5978. https://doi.org/10.1002/anie.20060187810.1002/anie.200601878 ↗
37. Gao L, Chen Q, Gong T et al (2019) Recent advancement of imidazolate framework (ZIF-8) based nanoformulations for synergistic tumor therapy. Nanoscale 11(44):21030–21045. https://doi.org/10.1039/c9nr06558j10.1039/c9nr06558j ↗
38. Sun Q, Bi H, Wang Z et al (2019) Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal–organic frameworks for efficient antitumor therapy. Biomaterials 223:119473. https://doi.org/10.1016/j.biomaterials.2019.11947310.1016/j.biomaterials.2019.119473 ↗
39. Zhang J, Chen C, Li A et al (2021) Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection. Nat Nanotechnol 16(5):538–548. https://doi.org/10.1038/s41565-020-00843-710.1038/s41565-020-00843-7 ↗
40. Xiong Y, Wang Y, Tiruthani K (2019) Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer. Nanomedicine 21:102034. https://doi.org/10.1016/j.nano.2019.10203410.1016/j.nano.2019.102034 ↗
41. Su H, Sun F, Jia J et al (2015) A highly porous medical metal–organic framework constructed from bioactive curcumin. Chem Commun 51(26):5774–5777. https://doi.org/10.1039/c4cc10159f10.1039/c4cc10159f ↗
42. Grall R, Hidalgo T, Delic J et al (2015) In vitro biocompatibility of mesoporous metal (III; Fe, Al, Cr) trimesate MOF nanocarriers. J Mater Chem B 3(42):8279–8292. https://doi.org/10.1039/c5tb01223f10.1039/c5tb01223f ↗
43. Tamames-Tabar C, Cunha D, Imbuluzqueta E et al (2014) Cytotoxicity of nanoscaled metal-organic frameworks. J Mater Chem B 2(3):262–271. https://doi.org/10.1039/c3tb20832j10.1039/c3tb20832j ↗
44. Gimenez-Marques M, Bellido E, Berthelot T et al (2018) GraftFast surface engineering to improve MOF nanoparticles furtiveness. Small 14(40):e1801900. https://doi.org/10.1002/smll.20180190010.1002/smll.201801900 ↗
45. Li B, Yao X, Li J et al (2023) A tumor microenvironment-activated metal–organic framework-based nanoplatform for amplified oxidative stress-induced enhanced chemotherapy. J Biol Chem 299(1):102742. https://doi.org/10.1016/j.jbc.2022.10274210.1016/j.jbc.2022.102742 ↗
46. Hua Y, Qin M, Lu S et al (2024) Hyaluronic acid-functionalized MOFs for combined sunitinib and siRNA therapy in renal cell carcinoma. Int J Biol Macromol 283(Pt 1):137317. https://doi.org/10.1016/j.ijbiomac.2024.13731710.1016/j.ijbiomac.2024.137317 ↗
47. Cunha D, Ben Yahia M, Hall S et al (2013) Rationale of drug encapsulation and release from biocompatible porous metal–organic frameworks. Chem Mater 25(14):2767–2776. https://doi.org/10.1021/cm400798p10.1021/cm400798p ↗
48. Sun Y, Zheng L, Yang Y et al (2020) Metal–organic framework nanocarriers for drug delivery in biomedical applications. Nano-Micro Lett 12(1):103. https://doi.org/10.1007/s40820-020-00423-310.1007/s40820-020-00423-3 ↗
49. Muslim M, Ali A, Ahmad M (2024) Hydrothermal synthesis of metal–organic frameworks. In: Azim Y, Rather SU, Bhawani SA, Bhatt PM (eds) Synthesis of metal–organic frameworks via water-based routes. Elsevier, Amsterdam, pp 73–9210.1016/B978-0-323-95939-1.00011-3 ↗
50. Mahmoud MM (2025) Microwave-assisted fast synthesis of MOF-801. Next Mater 6:10031610.1016/j.nxmate.2024.100316 ↗
51. Abaszadeh N, Afzali D, Sargazi G et al (2024) Sonochemical-assisted method for efficient synthesis of Cu-MOF and evaluating its antibacterial properties. Heliyon 10(10):e31024. https://doi.org/10.1016/j.heliyon.2024.e3102410.1016/j.heliyon.2024.e31024 ↗
52. Letwaba J, Uyor UO, Mavhungu ML et al (2024) A review on MOFs synthesis and effect of their structural characteristics for hydrogen adsorption. RSC Adv 14(20):14233–1425310.1039/D4RA00865K ↗
53. Kumari S, Gusain M, Lamba BY et al (2025) A critical review on recent advancements in metal–organic frameworks for CO2 capture, storage and utilization. J Mater Chem A 13:21352–2138810.1039/D5TA02338F ↗
54. Vaid TP, Kelley SP, Rogers RD (2017) Structure-directing effects of ionic liquids in the ionothermal synthesis of metal-organic frameworks. IUCrJ 4(Pt 4):380–392. https://doi.org/10.1107/S205225251700832610.1107/S2052252517008326 ↗
55. Cui J, Gao N, Yin X et al (2018) Microfluidic synthesis of uniform single-crystalline MOF microcubes with a hierarchical porous structure. Nanoscale 10(19):9192–9198. https://doi.org/10.1039/c8nr01219a10.1039/c8nr01219a ↗
56. Zhu Z, Ouyang Q, Zhou L et al (2025) Current status and prospects of detection of breast cancer by MOFs platform. J Mol Struct 1321:13979710.1016/j.molstruc.2024.139797 ↗
57. Umar S, Samokhvalov A (2024) Encapsulation of gemcitabine on porphyrin aluminum metal–organic framework by mechano-chemistry, delayed drug release and cytotoxicity to pancreatic cancer PANC-1 cells. Molecules 29(13):3189. https://doi.org/10.3390/molecules2913318910.3390/molecules29133189 ↗
58. Zhang T, Sun Y, Cao J et al (2021) Intrinsic nucleus-targeted ultra-small metal–organic framework for the type I sonodynamic treatment of orthotopic pancreatic carcinoma. J Nanobiotechnology 19(1):315. https://doi.org/10.1186/s12951-021-01060-710.1186/s12951-021-01060-7 ↗
59. Sakamaki Y, Ozdemir J, Heidrick Z et al (2021) A bio-conjugated chlorin-based metal–organic framework for targeted photodynamic therapy of triple negative breast and pancreatic cancers. ACS Appl Bio Mater 4(2):1432–1440. https://doi.org/10.1021/acsabm.0c0132410.1021/acsabm.0c01324 ↗
60. Sun Y, Cao J, Wang X et al (2021) Hypoxia-adapted sono-chemodynamic treatment of orthotopic pancreatic carcinoma using copper metal–organic frameworks loaded with an ultrasound-induced free radical initiator. ACS Appl Mater Interfaces 13(32):38114–38126. https://doi.org/10.1021/acsami.1c1101710.1021/acsami.1c11017 ↗
61. Liu J, Yang L, Cao X et al (2021) PEGylated Mn containing MOF nanoparticles for potential immunotherapy of pancreatic cancer via manganese induced activation of anti-tumor immunity. Colloid Interface Sci Commun 42:100409. https://doi.org/10.1016/j.colcom.2021.10040910.1016/j.colcom.2021.100409 ↗
62. Eskandari A, Wang Y, Forgan RS. Potent activity of Metal–organic Framework nanoparticles loaded by hydrophobic natural products via one-pot synthetic method against pancreatic cancers. 202310.26434/chemrxiv-2023-mhb04 ↗
63. Nekoufar S, Ghorbani M, Safaei S et al (2025) Exploring the potential of gemcitabine-metal–organic frameworks in combating pancreatic cancer under ketogenic conditions. BMC Cancer 25(1):53. https://doi.org/10.1186/s12885-024-13397-x10.1186/s12885-024-13397-x ↗
64. Mady FM, Essa H, El-Ammawi T et al (2016) Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis. Drug Des Devel Ther 10:1101–1110. https://doi.org/10.2147/DDDT.S10342310.2147/DDDT.S103423 ↗
65. Lu K, He C, Lin W (2015) A chlorin-based nanoscale metal–organic framework for photodynamic therapy of colon cancers. J Am Chem Soc 137(24):7600–7603. https://doi.org/10.1021/jacs.5b0406910.1021/jacs.5b04069 ↗
66. Jiang H, Bao Q, Yang T et al (2024) Precision treatment of colon cancer using doxorubicin-loaded metal–organic-framework-coated magnetic nanoparticles. ACS Appl Mater Interfaces 16(37):49003–49012. https://doi.org/10.1021/acsami.4c0860210.1021/acsami.4c08602 ↗
67. Duan F, Hu M, Guo C et al (2020) Chromium-based metal–organic framework embedded with cobalt phthalocyanine for the sensitively impedimetric cytosensing of colorectal cancer (CT26) cells and cell imaging. Chem Eng J 398:12545210.1016/j.cej.2020.125452 ↗
68. Wang W, Wang L, Li Y et al (2016) Nanoscale polymer metal–organic framework hybrids for effective photothermal therapy of colon cancers. Adv Mater 28(42):9320–9325. https://doi.org/10.1002/adma.20160299710.1002/adma.201602997 ↗
69. Hang L, Li M, Zhang Y et al (2024) Mn(II) optimized sono/chemodynamic effect of porphyrin-metal–organic framework nanosheets for MRI-guided colon cancer therapy and metastasis suppression. Small 20(15):e2306364. https://doi.org/10.1002/smll.20230636410.1002/smll.202306364 ↗
70. Padya BS, Fernandes G, Hegde S et al (2023) Targeted delivery of 5-fluorouracil and sonidegib via surface-modified ZIF-8 MOFs for Effective basal cell carcinoma therapy. Pharmaceutics 15(11):2594. https://doi.org/10.3390/pharmaceutics1511259410.3390/pharmaceutics15112594 ↗
71. Sun X, Wang Q, Bao H et al (2024) Porphyrinic metal–organic framework PCN-224 nanoparticles for colocalization of nanoparticle-cargo in the skin and enhancement of sonodynamic efficacy. ACS Appl Nano Mater 7(3):2614–2629. https://doi.org/10.1021/acsanm.3c0467510.1021/acsanm.3c04675 ↗
72. Ebrahimpour A, Riahi Alam N, Abdolmaleki P et al (2020) Magnetic metal–organic framework based on zinc and 5-aminolevulinic acid: MR imaging and brain tumor therapy. J Inorg Organomet Polym Mater 31(3):1208–1216. https://doi.org/10.1007/s10904-020-01782-510.1007/s10904-020-01782-5 ↗
73. Lee S, Kim YY, Ahn HJ (2021) Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector. Biomaterials 272:120793. https://doi.org/10.1016/j.biomaterials.2021.12079310.1016/j.biomaterials.2021.120793 ↗
74. Chen L, Yu H, Li Y et al (2018) Fabrication of a microporous Dy(III)-organic framework with polar channels for 5-Fu (fluorouracil) delivery and inhibiting human brain tumor cells. Struct Chem 29(6):1885–1891. https://doi.org/10.1007/s11224-018-1168-310.1007/s11224-018-1168-3 ↗
75. Sharma A, Kumar A, Li C et al (2021) A cannabidiol-loaded Mg-gallate metal-organic framework-based potential therapeutic for glioblastomas. J Mater Chem B 9(10):2505–2514. https://doi.org/10.1039/d0tb02780d10.1039/d0tb02780d ↗
76. Pandya I, Kumar S, Aswal VK et al (2024) Metal organic framework-based polymeric hydrogel: a promising drug delivery vehicle for the treatment of breast cancer. Int J Pharm 658:124206. https://doi.org/10.1016/j.ijpharm.2024.12420610.1016/j.ijpharm.2024.124206 ↗
77. Li H, Zhang Y, Liang L et al (2022) Doxorubicin-loaded metal–organic framework nanoparticles as acid-activatable hydroxyl radical nanogenerators for enhanced chemo/chemodynamic synergistic therapy. Materials 15(3):109610.3390/ma15031096 ↗
78. Aldawsari MF, Anwer MK (2025) Synthesis of acalabrutinib loaded β-cyclodextrin-based metal–organic frameworks as a potential material for breast cancer therapy. Results Chem 16:102512. https://doi.org/10.1016/j.rechem.2025.10251210.1016/j.rechem.2025.102512 ↗
79. Javazm AB, Kashani GK, Matini A et al (2025) Label-free polyethylenimine@carbon quantum dots@Ni-metal–organic frameworks biosensing platform for highly sensitive detection of HER2-positive breast cancer biomarker. Microchem J 215:114120. https://doi.org/10.1016/j.microc.2025.11412010.1016/j.microc.2025.114120 ↗
80. Soman S, Kulkarni S, Vineeth P et al (2024) Harnessing nanotechnology for breast cancer management: UiO-66 (NH2) metal–organic frameworks functionalized with chitosan and folic acid for the efficient delivery of doxorubicin. Nano Struct Nano Objects 40:10136010.1016/j.nanoso.2024.101360 ↗
81. Fereydouni P, Al Mohaddesin A, Khaleghi S (2024) Targeted biocompatible Zn-metal–organic framework nanocomposites for intelligent chemotherapy of breast cancer cells. Sci Rep 14(1):18311. https://doi.org/10.1038/s41598-024-69457-610.1038/s41598-024-69457-6 ↗
82. Yu C-H, Hermosa GC, Sun A-C et al (2024) Monacolin-K loaded MIL-100(Fe) metal–organic framework induces ferroptosis on metastatic triple-negative breast cancer. Chem Eng J 498:154751. https://doi.org/10.1016/j.cej.2024.15475110.1016/j.cej.2024.154751 ↗
83. Xu Z, Zhou Z, Yang X et al (2024) Determining M2 macrophages content for the anti-tumor effects of metal–organic framework-encapsulated pazopanib nanoparticles in breast cancer. J Nanobiotechnol 22(1):429. https://doi.org/10.1186/s12951-024-02694-z10.1186/s12951-024-02694-z ↗
84. Singhal M, Riches-Suman K, Pors K et al (2024) Encapsulation and delivery of mitoxantrone using zirconium-based metal–organic frameworks (MOFs) and their cytotoxic potential in breast cancer cells. Appl Sci 14(5):190210.3390/app14051902 ↗
85. Gravan P, Rojas S, Picchi DF et al (2024) Towards a more efficient breast cancer therapy using active human cell membrane-coated metal–organic frameworks. Nanomaterials 14(9):784. https://doi.org/10.3390/nano1409078410.3390/nano14090784 ↗
86. Basha SS, Sasmal A, Ariraman S et al (2025) Cobalt-nickel metal–organic frameworks (CNM) as Drug delivery agent for triple-negative breast cancer. Nanoscale Adv 7:5361–537610.1039/D5NA00193E ↗
87. Abu Saleem E, Lafi Z, Shalan N et al (2025) Formation and evaluation of doxorubicin and cromoglycate metal-organic framework for anti-cancer activity. Nanomedicine 20(5):467–479. https://doi.org/10.1080/17435889.2025.245905910.1080/17435889.2025.2459059 ↗
88. Aldawsari MF, Anwer MK (2025) Synthesis of acalabrutinib loaded β-cyclodextrin-based metal–organic frameworks as a potential material for breast cancer therapy. Results Chem 16:10251210.1016/j.rechem.2025.102512 ↗
89. Sun L, Gao H, Wang H et al (2024) Nanoscale metal–organic frameworks-mediated degradation of mutant p53 proteins and activation of cGAS-STING pathway for enhanced cancer immunotherapy. Adv Sci 11(12):e2307278. https://doi.org/10.1002/advs.20230727810.1002/advs.202307278 ↗
90. Huang S, Yuan J, Xie Y et al (2023) Targeting nano-regulator based on metal–organic frameworks for enhanced immunotherapy of bone metastatic prostate cancer. Cancer Nanotechnol 14(1):43. https://doi.org/10.1186/s12645-023-00200-y10.1186/s12645-023-00200-y ↗
91. Hu J, Hu J, Wu W et al (2022) N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy. Acta Biomater 151:588–599. https://doi.org/10.1016/j.actbio.2022.08.02710.1016/j.actbio.2022.08.027 ↗
92. Li XY, Guan QX, Shang YZ et al (2021) Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer. World J Gastroenterol 27(26):4208–4220. https://doi.org/10.3748/wjg.v27.i26.420810.3748/wjg.v27.i26.4208 ↗
93. Raju P, Balakrishnan K, Mishra M et al (2022) Fabrication of pH responsive FU@ Eu-MOF nanoscale metal organic frameworks for lung cancer therapy. J Drug Deliv Sci Technol 70:10322310.1016/j.jddst.2022.103223 ↗
94. He Y, Xiong T, He S et al (2021) Pulmonary targeting crosslinked cyclodextrin metal–organic frameworks for lung cancer therapy. Adv Funct Mater 31(3):200455010.1002/adfm.202004550 ↗
95. Xiong T, Guo T, He Y et al (2023) Lactone stabilized by crosslinked cyclodextrin metal–organic frameworks to improve local bioavailability of topotecan in lung cancer. Pharmaceutics 15(1):14210.3390/pharmaceutics15010142 ↗
96. Wei D, Xin Y, Rong Y et al (2019) A mesoporous Gd-MOF with Lewis basic sites for 5-Fu delivery and inhibition of human lung cancer cells In Vivo and In Vitro. J Inorg Organomet Polym Mater 30(4):1121–1131. https://doi.org/10.1007/s10904-019-01305-x10.1007/s10904-019-01305-x ↗
97. Li D, Li L-F, Zhang Z-F et al (2020) Ultrasound-assisted synthesis of a new nanostructured Ca(II)-MOF as 5-FU delivery system to inhibit human lung cancer cell proliferation, migration, invasion and induce cell apoptosis. J Coord Chem 73(2):266–281. https://doi.org/10.1080/00958972.2020.172789510.1080/00958972.2020.1727895 ↗
98. Tian X, Yang L, Li Q et al (2025) Barbiturate derivative JL1 encapsulated with a hafnium-based MOF in poly(N-isopropylacrylamide) for non-small cell lung cancer therapy. ACS Appl Nano Mater 8(6):2926–2939. https://doi.org/10.1021/acsanm.4c0659710.1021/acsanm.4c06597 ↗
99. Wu MX, Yang YW (2017) Metal–organic framework (MOF)‐based drug/cargo delivery and cancer therapy. Adv Mater 29(23):160613410.1002/adma.201606134 ↗
100. Sadiq S, Khan S, Khan I et al (2024) A critical review on metal–organic frameworks (MOFs) based nanomaterials for biomedical applications: designing, recent trends, challenges, and prospects. Heliyon 10(3):e25521. https://doi.org/10.1016/j.heliyon.2024.e2552110.1016/j.heliyon.2024.e25521 ↗